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ABSTRACT 
 
PHENYLEPHRINE VERSUS EPHEDRINE:  SAFEST VASOPRESSOR FOR THE  
 
NEONATE DURING CAESAREAN SECTION 
 
by James Stacey Hale Jr.  
 
December 2015 
 
 One of the most common side effects of spinal anesthesia is the development of  
 
hypotension.  Data collected has determined that 80% of parturients that undergo spinal  
 
anesthesia for this mode of delivery experience hypotension (Chestnut et al., 2014).   
 
Hypotension, if sustained and severe, can lead to fetal hypoxia, neonatal depression or  
 
injury, and decreased uteroplacental perfusion. Hypotension can also cause severe health  
 
issues for the parturient including apnea, altered level of consciousness, cardiac arrest,  
 
and pulmonary aspiration. This systematic review of the literature was conducted to  
 
determine whether the administration of phenylephrine or ephedrine was safer for the  
 
neonate to administer to a hypotensive parturient during cesarean delivery while  
 
undergoing a spinal anesthetic.  Inclusion criteria included parturients that were classified  
 
as an American Society of Anesthesiologists physical status score of II that experienced  
 
hypotension after undergoing spinal anesthesia for elective cesarean section.  Exclusion  
 
criteria included any parturient classified as an ASA physical status score > 2, any  
 
cesarean section classified as emergent, or those parturients that received an epidural as  
 
the method of anesthesia for elective cesarean section.  A systematic review of the  
 
literature was performed and the results of randomized control trials and other studies  
 
were analyzed that measured neonatal outcomes following the administration of  
 
ephedrine and phenylephrine to the hypotensive parturient.  The results of these studies  
 
 
 
 iii 
were disseminated and the conclusions reached were implemented into a white paper  
 
change proposal. 
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CHAPTER I 
 
INTRODUCTION 
 
Statement of the Problem 
 
The most commonly performed major surgical procedure in the United States 
today is cesarean delivery, accounting for more than 1 million procedures each year and 
approximately 30% of all births (Chestnut et al., 2014).  Cesarean delivery is most 
commonly defined as the birth of an infant through incisions made by the surgeon in the 
abdomen and uterus.  The most common indications for a cesarean delivery in parturients 
include malpresentation, shoulder dystocia, previous cesarean section, and nonreassuring 
fetal status.  Malpresentation is the presentation of any part of the fetus other than the 
back of the head during parturition. Shoulder dystocia is a serious complication that 
occurs during vaginal delivery.  After the head is delivered, the baby seems to be pulled 
back into the perineum due to anterior shoulder being trapped above the pubic symphysis. 
This complication occurs in as many as 3% of vaginal deliveries (Chestnut et al., 2014).  
Nonreassuring fetal status is a term used when test results suggest that the fetus’s health 
status may be in jeopardy because the fetus is not getting enough oxygen.  This 
complication usually occurs during labor in the late stages of pregnancy. Complications 
of cesarean delivery include uterine rupture, infection, hemorrhage, ureteral and bladder 
injury, abdominal pain, thromboembolism, and death.  Thromboembolism is the 
obstruction of a blood vessel with thrombotic material carried by the blood from the site 
of origin to plug another vessel.  The clot may plug a vessel in the brain, the lungs, the 
leg, the kidneys, or the gastrointestinal tract.  
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 The most commonly preferred method of anesthesia for elective cesarean section 
is with a neuraxial technique, which is a spinal, epidural, or a combined spinal epidural  
(Chestnut et al., 2014).  Of these three techniques, spinal anesthesia is the most 
commonly used technique.  Spinal anesthesia is a reliable and simple method that allows 
for correct needle placement by visual confirmation of the cerebrospinal fluid (Chestnut 
et al., 2014).  This technique is easier to perform than the epidural method of anesthesia.  
Spinal anesthesia delivers a fast onset of dense neuroblockade that is normally more 
profound than that which is provided by the epidural technique.  This results in a 
decreased rate of conversion to general anesthesia and the decreased need for 
supplemental intravenous analgesics.  The disadvantage to using the single shot spinal 
anesthetic method is it has a fixed duration of action and the anesthesia provider does not 
have the ability to redose without invasively performing the spinal technique again.  
Additionally, when spinal anesthesia is used as the anesthetic method for cesarean 
delivery it causes maternal hypotension at a rate of 80% (Chestnut et al., 2014). 
 One of the most common side effects of spinal anesthesia is the development of 
hypotension.  Hypotension is the medical definition for low blood pressure.  Blood 
pressure is the measure of the pressure in the arteries that is created by the contraction of 
the heart.  The physical process of pregnancy increases dependence on the sympathetic 
nervous system for the maintenance of systemic vascular resistance and venous return.  
This dependence coupled with the increased risk of aortocaval compression makes 
parturients more prone to hemodynamic instability and hypotension from neuraxial 
anesthesia (Chestnut et al., 2014).  Hypotension, if sustained and severe, can lead to fetal 
hypoxia, neonatal depression or injury, and decreased uteroplacental perfusion.  
3 
 
 
Hypotension can also cause severe health issues for the parturient including apnea, 
altered level of consciousness, cardiac arrest, and pulmonary aspiration.  Many strategies 
have been implemented to prevent the incidence of hypotension secondary to spinal 
anesthesia for cesarean delivery.  Some of these strategies are preoperative fluid 
administration, lower local anesthetic doses, left uterine displacement, vasopressor 
administration, and leg wrapping or elevation.  Left uterine displacement is the act of 
placing the patient in 15 degrees of left lateral tilt on the operating table. This prevention 
method is important to minimize aortocaval compression.  Aortocaval compression, or 
supine hypotension syndrome, is caused by compression of the inferior vena cava and 
aorta by the gravid uterus.  This syndrome can comprise uteroplacental blood flow by 
decreasing cardio output and venous return (Chestnut et al., 2014).   
 This capstone project will compare the effects of ephedrine versus phenylephrine 
in mothers undergoing spinal anesthesia during a cesarean delivery.  This project will 
examine the effects it has on neonates by performing a systematic review of the literature 
by comparing Apgar scores and fetal cord blood pH in cases where parturients received 
ephedrine and cases where they received phenylephrine.  Some deleterious effects can 
result in the neonate if impaired fetal oxygenation or fetal acidosis occurs.   
 Deleterious effects in the neonate that can occur are impaired fetal oxygenation 
with asphyxial distress, fetal acidosis, and decreased uteroplacental blood flow (Lee, 
Ngan Kee, & Gin, 2002). Although patients undergoing a spinal anesthetic are usually 
preloaded with intravenous fluids, a vasopressor is often required to treat hypotension 
after the spinal anesthetic takes effect.  Historically, the vasopressor of choice to treat 
hypotension for obstetric anesthesia has been ephedrine.  According to Lee et al. (2002), 
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this was based on observations researchers had when administering ephedrine to sheep.  
The study showed that ephedrine maintained and preserved uteroplacental blood flow 
better than other vasopressors.  It also was the most effective in increasing arterial 
pressure.  This effect is rationalized by the β-effect, which causes an increase in arterial 
blood pressure by increasing cardiac output rather than simply vasoconstriction.  
Phenylephrine, a pure α agonist, on the other hand, fell into disfavor as a vasopressor in 
obstetric anesthesia because of the decreased uteroplacental blood flow (Lee et al., 2002).  
However, controversy exists today because many trials have shown that phenylephrine is 
just as effective as ephedrine and has shown to possibly be a safer alternative for the 
neonate. 
Clinical Question 
 In parturients being treated for hypotension during cesarean section, does 
treatment with phenylephrine or ephedrine produce a higher Apgar score for the neonate 
while maintaining a normal arterial blood pH?   
Purpose of the Project 
 The purpose of this project was to search the literature to determine whether 
ephedrine or phenylephrine is safer for the neonate when administered to a parturient 
with hypotension during elective cesarean section.  The outcomes that were measured for 
this study were Apgar scores recorded at 1 and 5 minutes and umbilical artery pH.  These 
are standard assessments that are performed following the removal of the neonate during 
cesarean section that determine the current health status of the neonate.  
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CHAPTER II 
 
METHODOLOGY 
 
 After obtaining approval from the institutional review board (IRB) at the 
University of Southern Mississippi, a systematic search of literature on electronic 
databases was performed.  Databases that were used in this search were the Cochrane 
Library, Google Scholar, PubMed, and MEDLINE.  The search strategy that was 
incorporated was the search for the following key words in the text:  “hypotension”, 
“cesarean delivery”, “phenylephrine”, “ephedrine”, “spinal anesthesia”, and “neonatal 
outcomes after spinal induced hypotension.”  The outcomes measured were Apgar scores 
at 1 and 5 minutes and umbilical arterial and venous pH values.  These outcomes were 
measured after the parturient was administered phenylephrine, ephedrine, or both for the 
treatment of hypotension secondary to spinal anesthesia for elective cesarean section. The 
results of these studies were compiled and the conclusions reached were utilized in the 
development of a white paper change proposal.  This white paper change proposal was 
distributed among local clinical sites to prevent the occurrence of fetal acidosis and 
decreased Apgar scores following the administration of ephedrine and phenylephrine 
during elective cesarean section.   
Target Outcome 
 The goal of this capstone was to determine whether it is safer for the neonate to 
administer ephedrine or phenylephrine to the hypotensive parturient during cesarean 
delivery.  The desired outcome was to improve patient safety by developing a practice 
change policy based upon the findings of the systematic review of the literature.  The 
findings of this systematic review of the literature was implemented into a white paper 
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change proposal and distributed to local clinical sites to increase knowledge on use of 
these vasopressors, their effect on neonates and implications for decision-making and 
clinical practice.  This capstone project will hopefully contribute to decreasing the 
occurrence of fetal acidosis and decreased Apgar scores following the administration of 
ephedrine and phenylephrine during elective cesarean section.   
Barriers 
 Several barriers were identified while performing this capstone project. There 
were a limited amount of studies that measured the same neonatal outcomes when 
comparing the administration of ephedrine versus phenylephrine to hypotensive 
parturients following the administration of spinal anesthesia for cesarean delivery.  
Additional barriers included finding studies that were completed within the last 10 years, 
time constraints to complete the project, and studies that met the proper inclusion criteria.   
Population 
 The population chosen for this capstone project was women over the age of 18 
who were classified as an American Society of Anesthesiologists physical status score of 
II that experienced hypotension after undergoing spinal anesthesia for elective cesarean 
section.  Anesthesia providers use the ASA scoring system to classify and define relative 
risk prior to surgical anesthesia and conscious sedation.  An ASA physical status score of 
II is defined as a patient with mild systemic disease with no functional limitations  
(Butterworth, Mackey, & Wasnick, 2013). Additionally, they had to be treated with 
ephedrine, phenylephrine, or both. Exclusion criteria included any parturient classified as 
an ASA physical status score > 2, any cesarean section classified as emergent, or those 
parturients that received an epidural as the method of anesthesia for elective cesarean 
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section.  An ASA physical status score of III is defined as patients with severe systemic 
disease with some functional limitations (Butterworth et al., 2013). A total of nine studies 
met this criteria and were included in this systematic review of the literature.   
The Importance of Apgar Scores 
 The Apgar scoring system has been used to access the prognosis and overall 
condition of the neonate since Virginia Apgar introduced it in 1952 (Casey, McIntire, & 
Leveno, 2001).  Dr. Apgar in her paper A Proposal for a New Method of Evaluation of 
the Newborn Infant, described a simple and very reliable system for evaluating neonates 
that revealed a way to detect physiological differences among neonates whose mothers 
had been anesthetized for cesarean delivery by different techniques (Chestnut et al., 
2014).  The evaluation method she proposed was based on a 10-point scale that observed 
and measured five characteristics of newborns after delivery.  This method measured the 
neonate’s color, respiratory effort, muscle tone, heart rate, and reflex irritability (Casey et 
al., 2001).  Reflex irritability is the neonate’s response to a stimulus that is usually 
created by oropharyngeal suctioning.  The appropriate response is for the neonate to 
actively cough or sneeze (Chestnut et al., 2014).  After each of these easily identifiable 
characteristics are assessed, they are then assigned a score on a scale from 0 to 2.  The 
scores are then added up to achieve a max score of 10 and that allows the providers an 
easy way to evaluate the health status of the newborn.  Overall, a score of 7 or higher 
indicates that the neonate’s health condition is good to excellent.  Apgar scores from 4 to 
6 are considered fair for the neonate.  The infant’s physical status is considered to be poor 
with Apgar scores less than 4 (Chestnut et al., 2014).  The Apgar score rapidly evaluates 
the physical condition of neonates and is measured at 1 minute and 5 minutes after 
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delivery.  The 5-minute score has commonly been regarded as the best predictor of the 
neonate’s survival in clinical practice (Casey et al., 2001).   
 The Apgar score has come under scrutiny as the standard scoring system for 
newborns after delivery.  Many clinicians and clinical investigators believe that the 
measurement of pH in umbilical-artery blood is a more objective evaluation tool for 
assessing neonates.  Casey et al. (2001) conducted a retrospective cohort analysis to show 
that the Apgar score is still as valuable an assessment tool as it was during the last 60 
years.  The study included 151,891 live-born singleton infants without malformations 
who were delivered at 26 weeks of gestation or later.  The sample was collected from an 
inner-city public hospital from January 1988 to December 1998. The outcomes measured 
were paired Apgar scores at 1 and 5 minutes and umbilical-artery blood pH out of 
145,627 infants.  The study analyzed which test best predicted newborn death during the 
first 28 days after delivery.  The results showed that the risk of neonatal death in term 
neonates with five-minute Apgar scores of 0 to 3 was eight times the risk in term 
neonates with umbilical- artery blood pH values of 7.0 or less (Casey et al., 2001). Thus 
Casey, McIntire, and Leveno concluded that the five-minute Apgar score was a better 
predictor of neonatal outcome than was the measurement of umbilical-artery blood pH. 
The investigators determined that the Apgar scoring system is still a vital assessment tool 
and accurate predictor of newborn survival (Casey et al., 2001).   
The Importance of Umbilical-Artery Blood pH Measurements 
 The umbilical-artery blood pH measurement is a very important measurement and 
reflects the neonate’s physical condition after delivery. According to Omo-Aghoja 
(2014), the 26th Royal College of Obstetricians and Gynecologists study group on 
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Intrapartum Fetal Surveillance recommended the measurement of umbilical blood pH and 
base deficit as a tool to assess the neonate’s condition at birth. These measurements can 
be and are largely considered a more objective indication of a newborn’s condition than 
the Apgar score.  Obtaining the blood sample and receiving the results however can be 
delayed so an assessment of the neonate should immediately be done while awaiting 
feedback from the umbilical blood gas (Omo-Aghoja, 2014).  The American Congress of 
Obstetricians and Gynecologists has recommended that cord blood pH measurements be 
obtained in circumstances of low 5-minute Apgar score, abnormal fetal heart rate tracing, 
severe growth restriction, cesarean delivery for fetal compromise, intrapartum fever, 
multiple gestation, and maternal thyroid disease.  
 The major components of the umbilical cord blood that are analyzed are the pH, 
PCO2, HCO3
-, and PO2 (Chestnut et al., 2014).  HCO3
-, or Bicarbonate, is one of the 
major buffers in the blood of the neonate (Omo-Aghoja, 2014).  Another component of 
the umbilical blood gas that is measured is the base excess or base deficit. The base 
excess or deficit is basically a measure of the change in the buffering capacity of the 
neonate’s umbilical cord blood. This value can be determined by the HCO3-, PCO2, and 
pH.  When the obstetrician obtains the umbilical cord sample, it is usually to obtain a 
sample from both the umbilical vein and the umbilical artery.  The umbilical vein 
measurements reveal the quality of uteroplacental gas exchange and the condition of the 
parturient (Chestnut et al., 2014).  The umbilical artery measurements reflect the 
condition of the neonate.   
 According to Omo-Aghoja (2014), small changes in pH can significantly affect 
the function of various organ systems in the neonate including the cardiovascular system 
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and the central nervous system.  Fetal distress and a low Apgar score often accompany 
this development.  The common pH range for neonatal acidemia in most literature is from 
7.00 to 7.2.  However, there is a more significant correlation with adverse neonatal 
outcomes when umbilical cord pH is less than 7.0 (Omo-Aghoja, 2014).  According to 
Omo-Aghoja, the fetal acid-base status correlates well with the Apgar scores of the 
neonate.  Exceptions can occur however in preterm infants, so clinician diligence and the 
use of multiple assessment tools could be the most beneficial for the neonate.   
 Several factors can affect the umbilical arterial blood pH measurement.  Neonates 
that endure the stresses of labor tend to have lower pH measurements when compared to 
neonates who were born via cesarean delivery without experiencing labor (Chestnut et 
al., 2014).  Neonates who are born to nulliparous women also have been documented to 
have a lower pH than those who were born to parous women.  Nulliparous women are 
women that have not previously had a child.  Parous women are those that have delivered 
at least one child previously (Chestnut et al., 2014). Additionally, some studies have 
yielded results that suggest that preterm infants have a higher incidence of acidemia when 
compared to term infants.  Preterm infants also routinely receive poor Apgar scores even 
though their umbilical blood gas measurements are considered normal  (Chestnut et al., 
2014).  This is significant and provides another rationale for more than one method to be 
used to assess the neonate after delivery.   
Preventative Measures Currently Recommended to Prevent Hypotension  
 The most common preventive strategy used by anesthesia providers today is 
intravenous fluid administration (Chestnut et al., 2014).  The success of preventing 
hypotension intraoperatively during cesarean section depends on the type of fluid 
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administered whether it is a colloid or a crystalloid, the timing of the administration of 
fluid, and the rate of fluid administration.  A colloid is considered intravenous fluids 
containing large molecules and proteins that tend to stay within the vascular space.  
Examples of colloid solutions are Hetastarch, Albumin, and Dextran.  Crystalloid 
intravenous fluids are those that contain various concentrations of electrolytes and tend to 
diffuse more readily out of the vascular space than colloid solutions.  Common 
crystalloid solutions are Lactated Ringers, Dextrose 5%, and Normal Saline.  Some 
studies conducted on this preventive therapy have determined crystalloids to be 
minimally effective even administered at volumes of 2,000 milliliters to 3,000 milliliters.  
A study conducted by Ueyama and others determined that after 30 minutes post 
administration of a crystalloid solution that only 28% remained in the intravascular space.  
In contrast, the administration of a colloid solution is a more promising alternative for 
preventative therapy.  The same study conducted by Ueyama on crystalloid 
administration compared it to the administration of a colloid solution.  The researchers 
discovered that 30 minutes after the administration of a colloid that 100% of the solution 
remained in the vascular space.  However, the side effects to the administration of a 
colloid solution to parturients make this an unpopular option to many anesthesia 
providers.  Some side effects of colloid administration that have been noted are allergic 
reactions, pruritus, and coagulation abnormalities.  The next step in treating hypotension 
after intravenous fluid administration and the most successful option is the administration 
of vasopressors. 
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Use of Vasopressors 
Vasopressors are drugs that are administered that cause the constriction of blood 
vessels.  This desired constriction of blood vessels results in an increase in blood 
pressure. The main component common to all vasopressors is their ability to mimic some 
of the sympathetic nervous system actions (Macarthur & Riley, 2007).  The basic 
components that differentiate the vasopressors are each drug’s ability to stimulate the 
alpha or beta-receptor.  Sympathomimetics all have the same basic structure, which 
include the benzene ring based β-phenylenthylamine.  According to Macarthur and Riley 
(2007), the activity of the α and β-receptor is maximized if hydroxyl groups are attached 
at the third and fourth carbons of the benzene ring.  Compounds are considered synthetic 
noncatecholamines if they do not have the hallmark hydroxyl groups on the third and 
fourth carbons.   The two most commonly used vasopressors in anesthesia practice are 
ephedrine and phenylephrine and they are both included in the synthetic 
noncatecholamine group.   
Comparison of the Vasopressors Ephedrine and Phenylephrine 
 Ephedrine is a synthetic noncatecholamine sympathomimetic that stimulates both 
alpha and beta-receptors directly and causes the release of endogenous catecholamines 
indirectly that leads to several mechanisms of action (Nagelhout & Plaus, 2014).   The 
indirect effects of ephedrine are due to the stimulation of postganglionic sympathetic 
nerve endings to release norepinephrine (Macarthur & Riley, 2007).  Ephedrine produces 
increases in blood pressure, heart rate, systemic vascular resistance, and cardiac output.  
Ephedrine is not metabolized by monoamine oxidase enzyme deamination because it has 
a α-methyl group.  Additionally, catchol-O-methyltranserease enzymes do not metabolize 
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it because it lacks the traditional hallmark hydroxyl groups.  Consequently, its actions are 
mainly terminated by reuptake in terminal nerve endings.  Due to this, ephedrine is 
primarily excreted relatively unchanged in urine (Macarthur & Riley, 2007).  The dosage 
of ephedrine ranges from 5 mg to 25 mg and has an immediate onset of action when 
given via the intravenous route.  The duration of action has been documented to last from 
15 minutes up to 90 minutes usually based on the dosage given.  The administration of 
repeated 5 to 10 mg doses of Ephedrine can lead to tachyphylaxis, which results in a 
significant decrease in the efficacy of the drug after subsequent dosing. 
 Phenylephrine is a direct acting pure alpha agonist that is commonly administered 
to parturients that have episodes of hypotension during cesarean section.  Phenylephrine 
is considered a pure alpha agonist because it has strong alpha stimulating effects with 
essentially no beta stimulation (Nagelhout & Plaus, 2014).  Phenylephrine is metabolized 
by rapid inactivation by monamine oxidase and catchol-O-methyltranserease. The dosage 
of phenylephrine commonly administered intravenously is 50 to 200 micrograms and has 
an immediate onset of action.  According to Macarthur and Riley (2007), because of its 
short duration of action, phenylephrine can also be administered by intravenous infusion 
of 20 to 50 micrograms per minute. The duration of action of phenylephrine ranges from 
5 to 20 minutes.  Phenylephrine can cause a sharp rise in blood pressure due to the 
significant increase in peripheral vasoconstriction by stimulating alpha-1 receptors.  A 
common side effect of phenylephrine is a reflex bradycardia that is produced after 
baroreceptor stimulation due to the significant increase in peripheral resistance.   
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What are Clinicians Using in Practice Now? 
 An electronic survey was conducted by Allen, Muir, George, and Habib that 
included 292 members of the Society for Obstetric Anesthesia and Perinatology between 
February and March 2007 to determine their preferences for preventing and treating 
spinal-induced hypotension.  Of the members using vasopressors for prophylaxis, 26% 
used phenylephrine, 32% used ephedrine, and 33% based their choice on the parturient’s 
heart rate.  The group determined that for treatment, 23% used phenylephrine, 32% used 
ephedrine, and 41% used either based on heart rate.  The group concluded that significant 
variations exist in the prevention and treatment of hypotension due to spinal anesthesia 
but that ephedrine continues to be a more commonly used vasopressor than 
phenylephrine.   
Clinical Question 
 The incidence of hypotension is prevalent in parturients undergoing spinal 
anesthesia for cesarean delivery.  Cesarean deliveries account for 30% of all births in the 
United States.  The current anesthetic method of choice for cesarean delivery is spinal 
anesthesia.  Data collected determined that 80% of parturients that undergo spinal 
anesthesia for this mode of delivery experience hypotension. A clinical question was 
developed to determine whether the administration of phenylephrine or ephedrine was 
safer for the neonate to administer to a hypotensive parturient during cesarean delivery 
while undergoing a spinal anesthetic.  In parturients being treated for hypotension during 
cesarean section, does treatment with phenylephrine or ephedrine produce a higher Apgar 
score for the neonate while maintaining a normal arterial blood pH?   
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Research Strategies 
 To ascertain which vasopressor treatment modality for maternal hypotension is 
more beneficial for the neonate during elective cesarean delivery, a systematic review of 
the literature was conducted.  A systematic review is a study that focuses on a research 
question that attempts to identify and appraise research evidence relevant to that question.  
Inclusion criteria included in this study were parturients that underwent spinal anesthesia 
for elective cesarean section, were classified as ASA class II, and were treated with either 
ephedrine or phenylephrine. 
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CHAPTER III 
SYSTEMATIC REVIEW OF LITERATURE 
 
 Traditionally, ephedrine has been the drug of choice in obstetrics to treat maternal 
hypotension following neuraxial anesthesia.  The rationale behind this line of thinking 
from anesthesia providers was it was believed based on previous studies that ephedrine 
maintains uterine blood flow better than phenylephrine.  However, the most recent 
studies indicated that phenylephrine has now been recommended as the first drug choice 
following neuraxial anesthesia.  The most commonly preferred method of anesthesia for 
elective cesarean section is with a neuraxial technique, which is a spinal, epidural, or a 
combined spinal epidural (Chestnut et al., 2014). Of these three techniques, spinal 
anesthesia is the most commonly used technique. Spinal anesthesia delivers a fast onset 
of dense neuroblockade that is normally more profound than that which is provided by 
the epidural technique.  Lee et al. (2002) performed a quantitative, systematic review of 
randomized controlled trials of ephedrine versus phenylephrine for the management of 
hypotension during cesarean delivery while under spinal anesthesia.  The authors 
performing the systematic review compared the efficacy and safety of ephedrine and 
phenylephrine for the treatment and prevention of hypotension during cesarean delivery 
while undergoing spinal anesthesia.  In the study, seven randomized control trials were 
eligible for use after the systematic search of electronic databases.  The outcomes they 
measured and assessed were maternal hypertension, hypotension, and bradycardia.  
Neonatal Apgar scores and umbilical cord pH blood values were also studied.  The 
authors determined from the results that there was no difference between ephedrine and 
phenylephrine in their efficacy for managing maternal hypotension (Lee et al., 2002).  
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However, maternal bradycardia was more likely to occur with phenylephrine than with 
ephedrine (relative risk of 4.79; 95% confidence interval, 1.47-15.60).  Neonatal 
umbilical arterial pH values were higher in women who were treated with phenylephrine 
as compared to those treated with ephedrine.  The authors determined from the results 
that there was no difference between ephedrine and phenylephrine in the incidence of 
Apgar scores less than 7 at 1 and 5 minutes and true fetal acidosis, which is umbilical 
arterial pH value less than 7.2 (Lee et al., 2002).  Lee et al. did not support the traditional 
practice that ephedrine is the drug of choice for the management of maternal hypotension 
during cesarean delivery while under spinal anesthesia.   
 Magalhaes, Goveia, de Araujo Ladeira, Nascimento, and Cavalcante Kluthcouski 
(2009) conducted a randomized, double blind, prospective study with 60 women.  The 
women were separated randomly into two groups using sequential, sealed envelopes with 
random numbers generated by a computer. The group studied the incidence of maternal 
hypotension, maternal bradycardia, vomiting, Apgar scores at 1 and 5 minutes, and blood 
gases of the neonatal umbilical cord blood.  The 60 patients underwent spinal anesthesia 
for cesarean section with bupivacaine and sufentanil and were divided into two groups to 
receive prophylactic phenylephrine (Group P, n = 30, dose = 80 mcg) and ephedrine 
(Group E, n = 30, dose = 10 mg).  According to Nagelhout and Plaus (2014), bupivacaine 
is traditionally the local anesthetic of choice when administering spinal anesthesia for 
cesarean delivery.  In the United States, it is administered via the intrathecal route, or 
spinal route, and is formulated in a concentration of 0.75% in dextrose 8.25%. Sufentanil 
is a narcotic that is commonly administered intrathecally in conjunction with bupivacaine 
(Nagelhout & Plaus, 2014).  The definition of hypotension the group used in their study 
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was a blood pressure equal or lower than 80% of baseline values.  Maternal hypotension 
was treated with a bolus administration of the participant’s vasoconstrictor at 50% of the 
initial dose.  The results from the study determined that the mean dose of phenylephrine 
used was 186.7 +/- 52.9 and the mean dose of ephedrine used was 14.8 +/- 3.8 mg 
(Magalhaes et al., 2009).  The incidence of hypotension was 70% in the ephedrine group 
and 93% in the phenylephrine group.  The group determined that the Apgar scores in the 
first minute and the mean arterial pH of the neonatal umbilical cord blood were lower in 
the Ephedrine group.  The group determined that differences in the Apgar score in the 
fifth minute were not evident.  The authors concluded from the study that ephedrine was 
more effective than phenylephrine in the prevention of hypotension (Magalhaes et al., 
2009).  However, fetal repercussions were found to be less frequent with phenylephrine 
and were transitory with the administration of ephedrine.  
 An updated meta-analysis on ephedrine versus phenylephrine for the management 
of hypotension during cesarean section while undergoing spinal anesthesia was 
conducted by Lin, Qui, Ding, Fu, and Li (2012).  The aim of this study was to update a 
systematic literature review that was previously conducted on the same topic in 2002.  
The group used Medline, the Cochrane Library, and Embase Databases to search for the 
criteria.  The group examined a total of 15 trials and 742 parturients under elective 
Cesarean Sections.  They determined when patients received ephedrine and 
phenylephrine for prevention of hypotension; results did not significantly differ in the 
incidence of umbilical arterial pH values, hypotension, or venous pH values.  The group 
determined when ephedrine and phenylephrine were used to treat hypotension that the 
results indicated both had similar incidence of perioperative hypotension but those 
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patients receiving phenylephrine had neonates with higher venous pH values and 
umbilical arterial pH values than those who had received ephedrine (Lin et al., 2012).  
Thus, the group came to the conclusion that the prophylactic use of ephedrine and 
phenylephrine were both effective in preventing maternal hypotension during cesarean 
section under spinal anesthesia, but phenylephrine was superior to ephedrine in treating 
hypotension which was evidenced by higher umbilical cord arterial and venous pH 
values.   
 Adigun, Amanor-Boadu, and Soyannwo (2010) conducted a randomized, double- 
blind, controlled study of 62 parturients that compared intravenous ephedrine against 
phenylephrine for the maintenance of arterial blood pressure during elective caesarean 
section under spinal anaesthesia.  The parturients included were those that were classified 
as American Society of Anesthesiologists’ (ASA) class 1 or 2 at term with singleton 
pregnancy who consented to a subarachnoid spinal block.  The patients were injected 
with 2.5 milliliters of 0.5% hyperbaric Bupivicaine at L3-L4 levels after being preloaded 
with 10 milliliters per kilogram of crystalloid fluids (Adigun et al., 2010).  Phenylephrine 
100 micrograms or Ephedrine 5 milligrams was given for the maintenance of arterial 
blood pressure.  The group determined that both vasopressors efficiently restored both the 
systolic and the diastolic blood pressures and the mean Apgar scores were similar for the 
two groups.  Neither the phenylephrine group nor the ephedrine group had Apgar scores 
below the value of 8 (Adigun et al., 2010).  They concluded that phenylephrine was safe 
and can be used as effectively as ephedrine.   
 A randomized, double-blind study was performed by Prakash, Pramanik, 
Chellani, Salhan, and Gogia (2010) on parturients comparing the effects of bolus 
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administration of ephedrine and phenylephrine during spinal anesthesia for caesarean 
delivery.  In the study the group administered phenylephrine 100 micrograms or 
ephedrine 6 milligrams whenever the systolic blood pressure dropped less than 80% of 
the patient’s baseline blood pressure during the spinal block.  The group determined that 
changes in systolic were comparable in the two groups after the administration of the two 
vasopressors and there were essentially no differences in the incidence of nausea, 
bradycardia, and vomiting.  However, the group determined venous and umbilical artery 
pH blood values were significantly higher in the phenylephrine group as compared to the 
ephedrine group. Also, the umbilical artery base excess was significantly less in the 
ephedrine group than in the phenylephrine group (Prakash et al., 2010).  Apgar scores at 
1, 5, and 10 minutes were measured as well as neurobehavioral scores at 2-4 hours, 24 
hours, and 48 hours and were determined to be similar in the two vasopressor groups.   
 Simin, Zahra, Pouya, and Reza (2012) conducted a prospective, double-blind, and 
case-controlled study on 60 parturients.  They studied the efficacy of ephedrine and 
phenylephrine in treatment of hypotension secondary to spinal anesthesia for cesarean 
section and the effects the two vasopressors had on the neonate.  The group randomly 
assigned the 60 parturients into an ephedrine group, which received boluses of 5 
milligrams, and a phenylephrine group, which received boluses of 100 micrograms, for 
treatment of hypotension after a subarachnoid spinal block during cesarean section.  They 
studied changes in maternal heart rate, maternal blood pressure, and the incidence of 
nausea and vomiting.  Additionally the group measured neonatal umbilical arterial blood 
gas values and Apgar scores at 1 minute and 5 minutes.  The group determined that both 
vasopressors were efficient at managing hypotension in parturients undergoing cesarean 
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section with comparable results.  Also there were no differences in Apgar scores at 1 
minute and 5 minutes after administration of either vasopressor.  There were only 
minimal differences in the umbilical artery pH and base excess values and there were not 
any incidents of true acidosis, pH less than 7.20, in any of the neonates.  Thus, the group 
concluded that both phenylephrine and ephedrine were both equally efficient at treating 
hypotension secondary to subarachnoid block during cesarean section and neither 
vasopressor presented a risk for adverse effects on neonates.   
 Cooper et al. (2002) performed a randomized, double- blind study on 147 
parturients to determine whether ephedrine, phenylephrine, or a combination of the two 
was the most efficient at treating hypotension secondary to spinal block and whether or 
not the two vasopressors caused adverse effects to the neonate.  The group randomly 
divided the patient groups into three different groups: a phenylephrine group which 
received 100 micrograms/milliliter, an ephedrine group which received 3 
milligrams/milliliter, and a combination group that received 50 micrograms/milliliter of 
phenylephrine and 1.5 milligrams/milliliter.  These groups were selected by envelope to 
one of the three vasopressor solutions to maintain maternal systolic pressure during spinal 
anesthesia.  The group determined that fetal acidosis was found to be more frequent in the 
ephedrine group (10 of 48) and less frequent in the phenylephrine group (1 of 48) and 
combination group (1 of 47).  The group also determined that there is no significance 
difference among the different vasopressor categories in regards to the measurement of 
Apgar scores.  All vasopressor groups had Apgar scores above 8 and are thus deemed 
insignificant. The group concluded that administering phenylephrine alone by infusion 
during spinal anesthesia for cesarean section was associated with a lower incidence of 
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maternal nausea and vomiting and fetal acidosis than giving ephedrine alone (Cooper et 
al., 2002).  Furthermore, the group determined that it was not advantageous to combine 
phenylephrine and ephedrine because it increased nausea and vomiting as compared to 
phenylephrine alone. It also did not improve fetal blood gas values additionally than from 
administering just phenylephrine.   
 A systematic literature search was conducted by Veeser et al. (2012) on 
comparing the administration of phenylephrine and ephedrine to hypotensive parturients 
after undergoing spinal anesthesia for cesarean section.  The outcomes they measured 
were the maternal and neonatal effects of the two vasopressors.  The authors study 
criteria was fulfilled by 20 trials, which included 1,069 patients.  The neonatal outcomes 
measured were umbilical-artery pH, base excess, and Apgar scores.  The investigators 
determined the relative ratio, or RR, of fetal acidosis was 5.29 (95%CI 1.62-17.25) for 
ephedrine compared with phenylephrine, which was statistically significant data (P = 
0.006) (Veeser et al., 2012).  Veeser et al. (2012) also determined that the data 
accumulated on base excess was significantly lower in the ephedrine group.  The 
weighted mean difference was -1.17 with a 95% confidence interval of -2.01 and P value 
of 0.006.  The number of neonates with Apgar values less than 7 were measured in 11 
trials at 1 and 5 minutes after delivery.  The only significant score present was a single 
Apgar value below 7 at 5 minutes in one study.  All other Apgar data when comparing 
phenylephrine to ephedrine was statistically insignificant.  The investigators concluded 
that ephedrine use was associated with an increased risk of true fetal acidosis when 
compared with phenylephrine.  Additionally, ephedrine use also increased the risk for a 
lower base excess value.  The study yielded that the Apgar values did not significantly 
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differ between the two vasopressors (Veeser et al., 2012).  The results of this study are 
clinically significant for my capstone project. 
 Loughrey et al. (2005) conducted a randomized control trial of 43 ASA I and II 
non-laboring women undergoing a planned, elective cesarean delivery.  The investigators 
randomized the 43 parturients into 2 groups.  The ephedrine only group received a bolus 
of ephedrine 10 milligrams intravenously.  The ephedrine and phenylephrine combine 
group received a bolus of phenylephrine 40 micrograms and ephedrine 10 milligrams 
simultaneously with spinal anesthesia (Loughrey et al., 2005).  The group defined 
hypotension for this study to be a decrease of 20% or greater from the baseline systolic 
value or any value less than 100 mmHg.  Loughrey et al. would give rescue boluses 
comprised of phenylephrine 20 micrograms and ephedrine 5 milligrams.  The results 
from the study yielded that the mean umbilical artery pH being 7.246 +/- 0.081 for the 
ephedrine only group and 7.244 +/- 0.106 for the combined ephedrine and phenylephrine 
group.  Apgar scores measured for the two groups were also similar and neither group 
had one that measured less than 7 (Loughrey et al., 2005). This study determines that 
there was no significant difference between the groups and that a combination of 
ephedrine with phenylephrine is not superior to ephedrine alone.   
Doctor of Nursing Practice Essentials 
 
 DNP Essential I is the scientific underpinning for practice (Chism, 2013).  This 
DNP essential allows the researcher to employ science-based theories and concepts to 
describe strategies used to improve healthcare delivery, to determine the importance and 
nature of health and healthcare delivery phenomena, and to evaluate outcomes.  The 
theory I plan to integrate into this capstone project is a middle-range theory.  Middle-
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range theory is a less abstract, has fewer propositions and concepts than grand theory, and 
is narrower in scope (Butts & Rich, 2011).  The type of theory I plan to integrate into the 
capstone project is the prescriptive theory or practice theory.   This model falls within 
Ernestine Wiedenbach’s model of nursing theory, The Helping Art of Clinical Nursing.  
The prescriptive theory is fundamentally based on three main factors: the central purpose 
which the clinical nurse recognizes as crucial to the particular discipline, the realities in 
the immediate situation that influence the central purpose, and the prescription for the 
fulfillment of the central purpose.  According to Butts and Rich (2011), prescriptive 
theory is an empirical, experimental theory for practice based on the effects of processes 
and actions on people and situations.  The use of this theory will help to discover whether 
phenylephrine or ephedrine is safer to administer in obstetric anesthesia.   
 DNP Essential II is the organizational and systems leadership for quality 
improvement and systems thinking (Chism, 2013).  This DNP essential employs 
scientific findings in nursing to evaluate and develop care delivery methods that meet the 
current and future needs of patient populations.   This capstone is designed to evaluate 
research conducted comparing the administration of phenylephrine and ephedrine to 
hypotensive parturients undergoing spinal anesthesia for cesarean section.  The method 
that will determine the difference between these two vasopressors is by measuring the 
neonates Apgar scores at 1 and 5 minutes and also by measuring fetal cord blood pH 
measurements.  Both vasopressors appropriately treat hypotension in the parturient but 
current research is controversial on which one is safer for the neonate.  This capstone 
intends to yield a clear answer on which is more beneficial for the neonate and a clinical 
practice change will be implemented to improve patient safety. 
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 DNP Essential III is the clinical scholarship and analytical methods for evidence-
based practice (Chism, 2013).  This DNP essential prepares the nurse researcher to 
critically and analytically evaluate existing literature and other evidence to determine the 
best evidence for practice.  This essential also aids in evaluating outcomes in practice 
within populations in various fields.  Additionally this essential helps the nurse researcher 
develop practice guidelines that are based on relevant, best-practice findings.  This 
capstone will systematically review research conducted by other researchers and will 
gather their results into a systematic review of the literature.  The results will then be 
synthesized into a white paper proposal for the treatment of spinal induced hypotension 
during cesarean section. 
 DNP Essential IV is the information systems and technology and patient care 
technology for the improvement and transformation of health care.  This DNP essential is 
paramount for the researcher in becoming proficient at the skills necessary to evaluate 
data extraction from practice information databases and systems.  This essential also aids 
the researcher to monitor and evaluate outcomes of care improvement by evaluating, 
designing, and using programs related to information technologies.  Electronic databases 
will be utilized for this capstone project to conduct my review of literature and to find 
relevant neonatal outcomes after cesarean delivery to supplement my research findings.  
Information technologies will also be employed to help synthesize the data into a meta-
analysis extracted from research studies. 
 DNP Essential V is healthcare policy for advocacy in healthcare (Chism, 2013).  
This essential is vital for the nurse researcher because it prepares them to provide 
leadership in the implementation and development of healthcare policy at the institutional 
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and local levels of healthcare, as well as the state and federal levels.  After the results of 
the capstone have been gleaned, a white paper proposal will be prepared to advocate for 
policy change at local clinical arenas in regards to obstetric anesthesia.  This will improve 
the quality of care and hopefully improve neonatal outcomes after cesarean section by 
treating parturient hypotension with the safest vasopressor.   
 DNP Essential VI is interprofessional collaboration for improving patient and 
population health outcomes (Chism, 2013).  This essential is critical because the DNP 
prepared nurse must participate in effective collaboration and communication throughout 
the development of practice guidelines, practice models, health policy, peer review, and 
standards of care.  The DNP prepared nurse must also examine complex organizational or 
practice issues through leadership of interprofessional teams.  Interprofessional 
collaboration is essential for the implementation of the practice change to be effective 
and to improve neonatal outcomes.  Additionally, communication with all anesthesia 
providers and department supervisors about the new white paper proposal is imperative 
for the latest evidenced based practice to be successfully implemented.   
 DNP Essential VII is clinical prevention and population health for improving the 
nation’s health.  According to Allan et al., clinical prevention is defined as reducing risk, 
illness prevention, and health promotion for families and individuals (Allan, et al., 2004).  
This essential prepares DNP level nurses to analyze biostatistical, environmental, 
epidemiological, and occupational data in the development, evaluation, and 
implementation of population health and clinical prevention (Chism, 2013).  The 
administration of ephedrine as a first line vasopressor for the prevention of hypotension 
in the parturient following spinal anesthesia for cesarean delivery can potentially lead to 
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decreased Apgar scores and fetal acidosis in the neonate.  Fetal acidosis in the neonate 
can lead to detrimental health complications like hypoxia, which can then potentially lead 
to cardiovascular collapse and mortality in the neonate.  By implementing the latest 
evidenced based practice based on the results of this capstone, neonatal complications 
can be avoided by administering phenylephrine as a first line vasopressor.   
 DNP Essential VIII is advanced nursing practice (Chism, 2013).  This essential is 
vital and prepares the DNP nurse to systematically assess health and illness parameters 
while incorporating culturally sensitive and diverse approaches.  By utilizing this DNP 
Essential, the DNP prepared nurse will also evaluate and implement therapeutic 
interventions based on nursing and other sciences.  Additionally, the DNP nurse will be 
able to utilize advanced critical thinking skills and deliver and evaluate evidence based 
care to improve patient outcomes.  The utilization of this DNP essential will lead the 
anesthesia provider to utilize the latest evidence based practice provided by this capstone 
and provide the most optimal care to the parturient during cesarean delivery.   
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White Paper Change Proposal 
  The most commonly performed major surgical procedure in the United States 
today is cesarean delivery, accounting for more than 1 million procedures each year and 
approximately 30% of all births. The most commonly preferred method of anesthesia for 
elective cesarean section is with a spinal anesthetic. Spinal anesthesia delivers a fast onset 
of dense neuroblockade that is normally more profound than that which is provided by 
the epidural technique. When spinal anesthesia is used as the anesthetic method for 
cesarean delivery, it causes maternal hypotension at a rate of 80%. Hypotension is the 
medical definition for low blood pressure.  Blood Pressure is the measure of the pressure 
in the arteries that is created by the contraction of the heart.  Hypotension, if sustained 
and severe, can lead to fetal hypoxia, neonatal depression or injury, and decreased 
uteroplacental perfusion. Although patients undergoing a spinal anesthetic are usually 
preloaded with intravenous fluids, a vasopressor is often required to treat hypotension 
after the spinal anesthetic takes effect.   
 Historically, the vasopressor of choice to treat hypotension for obstetric 
anesthesia has been ephedrine. This assumption was based on observations researchers 
had when administering ephedrine to sheep. In the study, ephedrine showed it maintained 
and preserved uteroplacental blood flow better than other vasopressors. It also was the 
most effective in increasing arterial pressure than other vasopressors. This effect is 
rationalized by the β-effect, which causes an increase in arterial blood pressure by 
increasing cardiac output rather than simply vasoconstriction. Phenylephrine, a pure α 
agonist, on the other hand had fell into disfavor as a vasopressor in obstetric anesthesia 
because of the decreased uteroplacental blood flow seen in the same sheep study.  A 
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systematic review of the literature was performed and the results of randomized control 
trials and other studies were analyzed that measured neonatal outcomes following the 
administration of ephedrine and phenylephrine to the hypotensive parturient. 
 The purpose of this project was to determine whether ephedrine or phenylephrine 
is safer for the neonate when administered to a hypotensive parturient during elective 
cesarean section. The desired outcome was to improve patient safety by developing a 
practice change policy based upon the findings of the systematic review of the literature.  
The outcomes that were measured for this study to determine this was Apgar scores 
recorded at 1 and 5 minutes and umbilical artery pH. These are standard assessments that 
are performed following the removal of the neonate during cesarean section that 
determine the current health status of the neonate.  
 One of the major findings of this systematic review of the literature was that there 
was no significant difference in Apgar scores when comparing the administration of 
ephedrine and phenylephrine.  There were eight studies reviewed in this capstone project 
that measured Apgar scores comparing ephedrine versus phenylephrine, and seven of 
them determined that there was no significant difference.  The value that was deemed 
significant in these studies was an Apgar value below seven.  In one study, the 
administration of ephedrine to the parturient during cesarean delivery caused lower 
Apgar scores at 1 minute, but when the measurement was repeated at five minutes it was 
above seven and considered normal.  The 5-minute score has commonly been regarded as 
the best predictor of the neonate’s survival in clinical practice. 
 The second neonatal outcome that was reviewed in this systematic review was the 
measurement of umbilical pH values.  The results of the review yielded some significant 
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and interesting results. There were eight studies in this capstone project that measured 
neonatal umbilical pH values. After reviewing these studies, five confirmed that 
ephedrine causes lower umbilical pH values in the neonate when given to the parturient 
during cesarean delivery. The other three studies deemed the results to be similar or 
insignificant in their findings. Small changes in pH can significantly affect the function of 
various organ systems in the neonate including the cardiovascular system and the central 
nervous system.   
 Based on the information discovered by this capstone project, phenylephrine is 
just as safe for neonates as ephedrine and is safer in regards to neonatal umbilical pH 
values. This capstone recommends the use of phenylephrine over ephedrine as a first line 
vasopressor to treat maternal hypotension during cesarean delivery secondary to spinal 
anesthesia. It is also recommended that the proposed changes made with the white paper 
proposal be tested for accuracy to determine if the results of the studies are significant 
enough to warrant a wholesale clinical practice change.  
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CHAPTER IV 
SUMMARY 
 The purpose of this project was to determine whether ephedrine or phenylephrine 
was safer for the neonate when administered to a hypotensive parturient during elective 
cesarean section.  The outcomes that were measured for this study to determine this was 
Apgar scores recorded at 1 and 5 minutes and umbilical artery pH.  These are standard 
assessments that are performed following the removal of the neonate during cesarean 
section that determine the current health status of the neonate.  A systematic review of the 
literature was performed and the results of randomized control trials and other studies 
were analyzed that measured neonatal outcomes following the administration of 
ephedrine and phenylephrine to the hypotensive parturient. 
Summary of Findings 
 One of the major findings of this systematic review of the literature was that there 
was no significant difference in Apgar scores when comparing the administration of 
ephedrine and phenylephrine.  There were eight studies reviewed in this capstone project 
that measured Apgar scores comparing ephedrine versus phenylephrine, and seven of 
them determined that there was no significant difference.  The value that was deemed 
significant in these studies was an Apgar value below 7.  In one study, the administration 
of ephedrine to the parturient during cesarean delivery caused lower Apgar scores at 1 
minute, but when the measurement was repeated at 5 minutes it was above 7 and 
considered normal.  The 5-minute score has commonly been regarded as the best 
predictor of the neonate’s survival in clinical practice (Casey et al., 2001).   
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The second neonatal outcome that was reviewed in this systematic review was the 
measurement of umbilical pH values.  The results of the review yielded some significant 
and interesting results.  There were eight studies in this capstone project that measure 
neonatal umbilical pH values.  After reviewing these studies, five confirmed that 
ephedrine causes lower umbilical pH values in the neonate when given to the parturient 
during cesarean delivery.  The other three studies deemed the results to be similar or 
insignificant in their findings.  This is significant because the majority of the studies 
determined that there is a correlation between the administration of ephedrine to 
parturients and lower umbilical pH measurements in neonates.  Historically, the 
vasopressor of choice to treat hypotension for obstetric anesthesia has been ephedrine.  
However, this capstone has shown that phenylephrine is just as effective as ephedrine and 
has shown to possibly be a safer alternative for the neonate based on the reviewed 
measurements of neonatal umbilical pH values. 
Recommendations 
 The review of literature showed that there was little to no significant difference 
when comparing ephedrine and phenylephrine and the measurement of neonatal Apgar 
scores.  However, the literature review did yield interesting results and the majority 
determined that ephedrine did cause a lower pH when compared with phenylephrine.  
This is a significant correlation and one that needs to be studied further for greater 
accuracy.  This capstone project proposes that changes made with the white paper 
proposal be tested for accuracy to determine if the results of the studies are significant 
enough to warrant a wholesale clinical practice change.   
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Conclusion 
 The goal of this capstone was to determine whether it is safer for the neonate to 
administer ephedrine or phenylephrine to the hypotensive parturient during cesarean 
delivery.  The desired outcome was to improve patient safety by developing a practice 
change policy based upon the findings of the systematic review of the literature.  The 
findings of this capstone project may not have proven one vasopressor to be without 
question safer for neonates than the other.  However, this project did provide a correlation 
between decreased umbilical pH values and the administration of ephedrine to 
hypotensive parturients following the administration of spinal anesthesia for cesarean 
delivery.  It is my belief that this capstone project will be beneficial in providing local 
clinical sites with current evidence-based practice on the administration of ephedrine and 
phenylephrine to hypotensive parturients and the neonatal outcomes that each 
vasopressor causes.   
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